SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConygar Inv Regulatory News (CIC)

Share Price Information for Conygar Inv (CIC)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £14.02m
CIC Live PriceLast checked at - London Stock Exchange

Intraday Conygar Inv Share Chart

Holding(s) in Company

23 Sep 2009 15:42

RNS Number : 5568Z
Conygar Investment Company PLC(The)
23 September 2009
 



TR-1: notification of major interests in shares 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Conygar Investment Co plc

2. Reason for the notification   (please tick the appropriate box or boxes)

An acquisition or disposal of voting rights 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify): Change in Issued Share Capital Figure

X

3. Full name of person(s) subject to the notification obligation:

Funds under the discretionary management of Laxey Partners Ltd

4. Full name of shareholder(s) (if different from 3.):

Client Suisse Client Nominees UK Ltd and Vidacos Nominees Limited

5. Date of the transaction and date on which the threshold is crossed or reached:

21 September 2009 

6. Date on which issuer notified:

23 September 2009 

7. Threshold(s) that is/are crossed or reached:

Percentage Change

8. Notified details:

10.95% on 6 May 2008 

A: Voting rights attached to shares

Class/type of shares 

 if possible using the ISIN CODE

Situation previous to the Triggering transaction 

Resulting situation after the triggering transaction

Number of Shares 

Number of Voting Rights 

Number of shares 

Number of voting rights 

% of voting rights

Direct

Direct

Indirect 

Direct

Indirect

GB0033698720

4,446,198

4,446,198

4,446,198

4,446,198

3.84%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction 

Type of financial instrument 

Expiration date 

Exercise/ Conversion Period 

Number of voting rights that may be acquired if the instrument is exercised/ converted. 

% of voting rights

Resulting situation after the triggering transaction 

Type of financial instrument 

Exercise price

Expiration date

Exercise/ Conversion Period 

Number of voting rights instrument refers to 

% of voting rights

Nominal

Delta

Total (A+B+C)

Number of voting rights

% of voting rights

4,446,198 shares

3.84%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable :

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

15. Contact telephone number:

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOSSRKRRKUAR
Date   Source Headline
15th May 20267:00 amRNSInterim Results
1st Apr 202612:12 pmRNSTR-1: Notification of Major Holdings
1st Apr 20267:00 amRNSCompletion of Debt Facility Restructuring
26th Mar 20262:16 pmRNSTR-1: Notification of Major Holdings
13th Mar 20263:07 pmRNSTR-1: Notification of Major Holdings
3rd Mar 202612:35 pmRNSResults of Annual General Meeting
17th Feb 20269:51 amRNSTR-1: Notification of Major Holdings
3rd Feb 20267:00 amRNSDirector/PDMR Dealing
29th Jan 20267:00 amRNSDirector/PDMR Dealing
28th Jan 20267:00 amRNSZDP Buyback Update and Results
22nd Jan 20267:00 amRNSZDP Share Acquisition Programme
20th Jan 20267:00 amRNSPreliminary Results
19th Dec 20257:00 amRNSBarclays Loan Extension and Notice of Results
19th Dec 20257:00 amRNSBarclays Loan Extension and Notice of Results
7th Nov 20252:16 pmRNSCompletion of sale of land at Rhosgoch
7th Nov 202510:12 amRNSTR-1: Notification of Major Holdings
29th Oct 202512:50 pmRNSTR-1: Notification of Major Holdings
29th Oct 20259:00 amRNSTR-1: Notification of Major Holdings
27th Oct 20257:00 amRNSSale of land at Rhosgoch
17th Oct 20257:00 amRNSTR-1: Notification of Major Holdings
3rd Oct 202511:30 amRNSPartnership with Rhubarb
30th Sep 20253:16 pmRNSHolding(s) in Company
19th Aug 20257:00 amRNSSale of Virgin Active gym at The Island Quarter
11th Aug 202510:38 amRNSTR-1: Notification of Major Holdings
7th Aug 202511:55 amRNSTR-1: Notification of Major Holdings
27th May 20257:00 amRNSInterim Results
29th Apr 202511:39 amRNSChange of Registered Office
4th Apr 202511:35 amRNSTR-1: Notification of Major Holdings
31st Mar 20253:25 pmRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSSale of Holyhead Waterfront and Parc Cybi
21st Mar 202510:44 amRNSDebt facility restructuring
10th Mar 202510:52 amRNSTR-1: Notification of Major Holdings
27th Feb 20251:52 pmRNSTR-1: Notification of Major Holdings
28th Jan 20252:30 pmRNSResults of Annual General Meeting
27th Jan 20253:36 pmRNSTR-1: Notification of Major Holdings
13th Jan 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20249:55 amRNSResolution to grant planning permission
18th Dec 20247:00 amRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSAnnual Results
19th Nov 20244:52 pmRNSNotification of Major Holdings
15th Nov 20241:25 pmRNSNotification of Major Holdings
15th Oct 20249:18 amRNSNotification of Major Holdings
4th Sep 202411:40 amRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSNominated Adviser and Broker
12th Jun 20242:16 pmRNSDirector/PDMR Shareholding
4th Jun 202411:00 amRNSPractical completion of student accommodation
22nd May 20247:00 amRNSDirector/PDMR Shareholding
21st May 20244:13 pmRNSDirector/PDMR Shareholding
16th May 20244:25 pmRNSPurchase of long-leasehold of Virgin Active site
16th May 20247:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.